{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:40:59Z","timestamp":1791567659907,"version":"4.3.4"},"reference-count":36,"publisher":"Society of Nuclear Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,7,14]]},"published-print":{"date-parts":[[2025,9]]},"DOI":"10.2967\/jnumed.125.270167","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T14:45:11Z","timestamp":1753973111000},"page":"1400-1405","source":"Crossref","is-referenced-by-count":12,"title":["CD24 as a Novel Radiopharmaceutical Target for Hepatocellular Carcinoma"],"prefix":"10.2967","volume":"66","author":[{"given":"Hima","family":"Makala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Sheehan-Klenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woonghee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon-Yong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwamena E.","family":"Baidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Nambiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Choyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy E.","family":"Escorcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"2025090310401683000_66.9.1400.1","doi-asserted-by":"crossref","unstructured":"Torbenson MS . Hepatocellular carcinoma. In: Mounajjed T Chandan VS Torbenson MS , eds. Surgical Pathology of Liver Tumors. Springer International Publishing; 2015:169\u2013218.","DOI":"10.1007\/978-3-319-16089-4_7"},{"key":"2025090310401683000_66.9.1400.2","doi-asserted-by":"publisher","DOI":"10.3322\/CAAC.21834"},{"key":"2025090310401683000_66.9.1400.3","doi-asserted-by":"crossref","first-page":"e0653","DOI":"10.1097\/HC9.0000000000000653","article-title":"Advances in radiation therapy for HCC: integration with liver-directed treatments","volume":"9","author":"Yariv","year":"2025","journal-title":"Hepatol Commun."},{"key":"2025090310401683000_66.9.1400.4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3350\/cmh.2019.0010","article-title":"Detect or not to detect very early stage hepatocellular carcinoma? The western perspective","volume":"25","author":"Yang","year":"2019","journal-title":"Clin Mol Hepatol."},{"key":"2025090310401683000_66.9.1400.5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/PPO.0000000000000435","article-title":"Radiomics, radiogenomics, and next-generation molecular imaging to augment diagnosis of hepatocellular carcinoma","volume":"26","author":"Bell","year":"2020","journal-title":"Cancer J."},{"key":"2025090310401683000_66.9.1400.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.10.024"},{"key":"2025090310401683000_66.9.1400.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.132118"},{"key":"2025090310401683000_66.9.1400.8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/molecules26010004","article-title":"Glypican-3-targeted alpha particle therapy for hepatocellular carcinoma","volume":"26","author":"Bell","year":"2020","journal-title":"Molecules."},{"key":"2025090310401683000_66.9.1400.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.265171"},{"key":"2025090310401683000_66.9.1400.10","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2967\/jnumed.121.262562","article-title":"Glypican-3 targeted 227Th \u03b1-therapy reduces tumor burden in an orthotopic xenograft murine model of hepatocellular carcinoma","volume":"63","author":"Labadie","year":"2021","journal-title":"J Nucl Med."},{"key":"2025090310401683000_66.9.1400.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266766"},{"key":"2025090310401683000_66.9.1400.12","doi-asserted-by":"crossref","unstructured":"Lee W Chung J-Y Baidoo KE . Glypican-3 as a radiotheranostic target for neuroendocrine prostate cancer. Eur Urol. May 21, 2025 [Epub ahead of print].","DOI":"10.1016\/j.eururo.2025.05.007"},{"key":"2025090310401683000_66.9.1400.13","doi-asserted-by":"publisher","DOI":"10.1126\/science.1168988"},{"key":"2025090310401683000_66.9.1400.14","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1456-0"},{"key":"2025090310401683000_66.9.1400.15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12964-023-01315-w","article-title":"Targeting CD24 as a novel immunotherapy for solid cancers","volume":"21","author":"Yang","year":"2023","journal-title":"Cell Commun Signal."},{"key":"2025090310401683000_66.9.1400.16","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2009.119"},{"key":"2025090310401683000_66.9.1400.17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41419-018-0681-z","article-title":"CD24 regulates sorafenib resistance via activating autophagy in hepatocellular carcinoma","volume":"9","author":"Lu","year":"2018","journal-title":"Cell Death Dis."},{"key":"2025090310401683000_66.9.1400.18","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0151"},{"key":"2025090310401683000_66.9.1400.19","doi-asserted-by":"crossref","first-page":"TPS2691","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS2691","article-title":"A first-in-human phase I study of ATG-031, anti-CD24 antibody, in patients with advanced solid tumors or B-cell non-Hodgkin lymphomas (PERFORM) [abstract]","volume":"42","author":"Fu","year":"2024","journal-title":"J Clin Oncol."},{"key":"2025090310401683000_66.9.1400.20","first-page":"240","article-title":"IMM47, a humanized monoclonal antibody that targets CD24, exhibits exceptional anti-tumor efficacy by blocking the CD24\/Siglec-10 interaction and can be used as monotherapy or in combination with anti-PD1 antibodies for cancer immunotherapy","volume":"6","author":"Li","year":"2023","journal-title":"Antib Ther."},{"key":"2025090310401683000_66.9.1400.21","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00432-017-2436-0","article-title":"Selective targeted delivery of doxorubicin via conjugating to anti-CD24 antibody results in enhanced antitumor potency for hepatocellular carcinoma both in\u00a0vitro and in\u00a0vivo","volume":"143","author":"Ma","year":"2017","journal-title":"J Cancer Res Clin Oncol."},{"key":"2025090310401683000_66.9.1400.22","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1053\/j.gastro.2010.12.004","article-title":"An immunoconjugate of anti-CD24 and Pseudomonas exotoxin selectively kills human colorectal tumors in mice","volume":"140","author":"Shapira","year":"2011","journal-title":"Gastroenterology."},{"key":"2025090310401683000_66.9.1400.23","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-2839"},{"key":"2025090310401683000_66.9.1400.24","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.62347\/TTNY4279","article-title":"Glypican-3 deficiency in liver cancer upregulates MAPK\/ERK pathway but decreases cell proliferation","volume":"14","author":"Chung","year":"2024","journal-title":"Am J Cancer Res."},{"key":"2025090310401683000_66.9.1400.25","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1016\/j.ijrobp.2020.07.966","article-title":"ImmunoPET as stoichiometric sensor for glypican-3 in models of hepatocellular carcinoma [abstract]","volume":"108","author":"Kelada","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2025090310401683000_66.9.1400.26","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.imbio.2015.07.010","article-title":"A novel antibody targeting CD24 and hepatocellular carcinoma in\u00a0vivo by near-infrared fluorescence imaging","volume":"220","author":"He","year":"2015","journal-title":"Immunobiology."},{"key":"2025090310401683000_66.9.1400.27","doi-asserted-by":"crossref","first-page":"101212","DOI":"10.1016\/j.adro.2023.101212","article-title":"Positron emission tomography (PET)\/computed tomography (CT) imaging in radiation therapy treatment planning: a review of PET imaging tracers and methods to incorporate PET\/CT","volume":"8","author":"Trotter","year":"2023","journal-title":"Adv Radiat Oncol."},{"key":"2025090310401683000_66.9.1400.28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41392-023-01366-y","article-title":"Molecular and functional imaging in cancer-targeted therapy: current applications and future directions","volume":"8","author":"Bai","year":"2023","journal-title":"Signal Transduct Target Ther."},{"key":"2025090310401683000_66.9.1400.29","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/s41416-018-0291-7","article-title":"CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer","volume":"119","author":"Ooki","year":"2018","journal-title":"Br J Cancer."},{"key":"2025090310401683000_66.9.1400.30","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16203"},{"key":"2025090310401683000_66.9.1400.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2010.12.011"},{"key":"2025090310401683000_66.9.1400.32","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.177857"},{"key":"2025090310401683000_66.9.1400.33","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1021\/jm500389b","article-title":"Alternative chelator for 89Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO)","volume":"57","author":"Deri","year":"2014","journal-title":"J Med Chem."},{"key":"2025090310401683000_66.9.1400.34","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.1002\/mco2.473","article-title":"Repurposing iron chelators for accurate positron emission tomography imaging tracking of radiometal-labeled cell transplants","volume":"5","author":"Xu","year":"2024","journal-title":"MedComm."},{"key":"2025090310401683000_66.9.1400.35","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/jlcr.3612","article-title":"Preclinical optimization of antibody-based radiopharmaceuticals for cancer imaging and radionuclide therapy\u2014model, vector, and radionuclide selection","volume":"61","author":"Carter","year":"2018","journal-title":"J Labelled Comp Radiopharm."},{"key":"2025090310401683000_66.9.1400.36","doi-asserted-by":"crossref","unstructured":"Pratt EC Mandleywala K Bauer D . Pretargeted Trop-2 immunoPET for rapid, selective detection of pancreatic tumors. Clin Cancer Res. 2025:2719\u20132726.","DOI":"10.1158\/1078-0432.CCR-24-3098"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.270167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T17:40:40Z","timestamp":1756921240000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.270167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,2]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.2967\/jnumed.125.270167"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.270167","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]}}}